Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health

Funding expands manufacturing readiness for Valley fever vaccine This follows Anivive’s $33MM NIAID contract for fungal vaccines In total, Anivive has secured over $80MM in contracts and preorders LONG BEACH, Calif., Jan. 27, 2025 /PRNewswire/ — Anivive Lifesciences, a software-driven…